DIRECT Trial - interferon alfacon-1 plus ribavirin DIRECT is a randomized, open-label, phase III investigational research study that will evaluate the safety and efficacy of daily administration of subcutaneous interferon alfacon-1 plus ribavirin versus no treatment in HCV patients who have not responded to previous combination therapy with pegylated interferon alfa plus ribavirin. Directtrial.com~Site InfoWhoisTrace RouteRBL Check
MSCCOP The Mount Sinai Community Clinical Oncology Program (MSCCOP) is a nonprofit community-based program committed to providing novel clinical research to cancer treatment patients and to healthy individuals who may be at risk for cancer. Mountsinaiccop.com~Site InfoWhoisTrace RouteRBL Check
The Center for Traditional Medicine The website of the Center for Traditional Medicine (CTM), Conducting research, education, and clinical treatment drawn from the universal knowledge and traditional systems of indigenous healing. Centerfortraditionalmedicine.org~Site InfoWhoisTrace RouteRBL Check
